Pursuant to Regulation 29 of the Listing Regulations, Ajanta Pharma has informed that a Meeting of the Board of Directors of the company will be held on Tuesday, 2nd February 2021 to consider and approve un-audited consolidated & standalone financial results of the Company for the third quarter ended 31st December 2020.
The above information is a part of company’s filings submitted to BSE.